Trypanosoma cruzi Evades the Complement System as an Efficient Strategy to Survive in the Mammalian Host: The Specific Roles of Host/Parasite Molecules and Trypanosoma cruzi Calreticulin.

作者: Galia Ramírez-Toloza , Arturo Ferreira

DOI: 10.3389/FMICB.2017.01667

关键词:

摘要: American Trypanosomiasis is an important neglected reemerging tropical parasitism, infecting about 8 million people worldwide. Its agent, Trypanosoma cruzi, exhibits multiple mechanisms to evade the host immune response and infect cells. An evasion strategy of T. cruzi infective stages its capacity inhibit complement system activation on parasite surface, avoiding opsonizing, stimulating lytic effects. Epimastigotes, non-infective form parasite, present in triatomine arthropod vectors, are highly susceptible complement-mediated lysis while trypomastigotes, form, bloodstream, resistant. Thus susceptibility varies depending stage (amastigote, trypomastigotes or epimastigote) strain. To avoid lysis, express surface a variety regulatory proteins, such as glycoprotein 58/68 (gp58/68), protein (TcCRP), trypomastigote decay-accelerating factor (T-DAF), C2 receptor inhibitor trispanning (CRIT) calreticulin (TcCRT). Alternatively, concomitantly, captures components with activity from H (FH) plasma membrane-derived vesicles (PMVs). All these proteins different steps classical (CP), alternative (AP) lectin pathways (LP). Thus, TcCRP inhibits CP C3 convertase assembling, gp58/68 AP convertase, T-DAF interferes convertases TcCRT LP, CRIT confers ability resist FH used by PMVs LP convertases. Many have similar molecular inhibitory mechanisms. Our laboratory has contributed elucidate role host-parasite interplay. we proposed that pleiotropic molecule, not only endoplasmic reticulum, but also participating key processes establish infection, inhibition serving virulence factor. Additionally, interaction components, participates anti-angiogenic anti-tumor inhibiting at least part, tumor growth infected animals.

参考文章(152)
Malhotra R, Collectin receptor (C1q receptor): structure and function. International workshop on C1, the first component of complement. pp. 254- 261 ,(1993)
V. D. Kallinikova, P. V. Matekin, T. A. Ogloblina, M. I. Leikina, A. F. Kononenko, N. M. Sokolova, L. S. Pogodina, Anticancer Properties of Flagellate Protozoan Trypanosoma cruziChagas, 1909 Biology Bulletin. ,vol. 28, pp. 299- 311 ,(2001) , 10.1023/A:1016636419597
Mark J. Walport, Complement. Second of two parts. The New England Journal of Medicine. ,vol. 344, pp. 1140- 1144 ,(2001) , 10.1056/NEJM200104123441506
Fernando Villalta, Felipe Kierszenbaum, Host-cell invasion by Trypanosomacruzi: Role of cell surface galactose residues Biochemical and Biophysical Research Communications. ,vol. 119, pp. 228- 235 ,(1984) , 10.1016/0006-291X(84)91642-5
J D Lambris, D Avila, J D Becherer, H J Müller-Eberhard, A discontinuous factor H binding site in the third component of complement as delineated by synthetic peptides. Journal of Biological Chemistry. ,vol. 263, pp. 12147- 12150 ,(1988) , 10.1016/S0021-9258(18)37905-5
Mark J. Walport, Complement. First of two parts. The New England Journal of Medicine. ,vol. 344, pp. 1058- 1066 ,(2001) , 10.1056/NEJM200104053441406
Valéry Combes, Nicolas Coltel, Mélanie Alibert, Miranda van Eck, Cécile Raymond, Irène Juhan-Vague, Georges Emile Grau, Giovanna Chimini, ABCA1 gene deletion protects against cerebral malaria: potential pathogenic role of microparticles in neuropathology. American Journal of Pathology. ,vol. 166, pp. 295- 302 ,(2005) , 10.1016/S0002-9440(10)62253-5